The story of bad-breath “miracle” products has always walked a fine line between innovation and overhype. At the center of one of the most notorious examples was Anthony Raissen, founder of the once-popular BreathAsure. Marketed as a revolutionary solution for chronic bad breath, BreathAsure claimed to neutralize odors from within the digestive system using parsley seed oil capsules. For a while, it was a household name.

But as sales skyrocketed, so did scrutiny. Regulators and watchdog groups flagged BreathAsure for unsubstantiated claims, forcing the company to halt its misleading advertising. Quackwatch and other consumer protection organizations called it out as an example of health-product misrepresentation. Allegations of fraud and misrepresentation followed, and soon after, BreathAsure collapsed.

Anthony Raissen, once hailed as an entrepreneurial success story, was left with a tarnished reputation.

Zelmin’s: A Familiar Formula with a New Face

Years later, a strikingly similar product appeared on the market: Zelmin’s Minty Mouth. Like BreathAsure, Zelmin’s promises to fight odor “from the inside out.” Each capsule has a minty coating for instant relief and an oil core (parsley seed oil among them) designed to neutralize odor at the digestive level. The resemblance to BreathAsure’s original formula is no coincidence.

But this time, the front man is not Anthony Raissen himself, but his son, Jarred Raissen. While Jarred presents Zelmin’s as a fresh, modern brand built for a health-conscious generation, industry insiders note the product’s lineage is clear. It is essentially a rebranded revival of the BreathAsure concept — with slicker packaging, toned-down marketing language, and a more careful embrace of buzzwords like “clinically tested” and “natural.”

Covering the Father’s Missteps

Positioning Jarred as the public face of Zelmin’s serves an obvious purpose: distancing the product from Anthony’s controversial history. BreathAsure’s downfall wasn’t just about a failed product — it became a symbol of overblown marketing and regulatory pushback.

By putting Jarred forward, Zelmin’s sidesteps the negative associations of Anthony’s name while still capitalizing on his original idea. To casual consumers, Zelmin’s looks like an innovative new brand; to those who know the backstory, it’s the same playbook in a new jersey.

This generational shift raises important questions: Is Zelmin’s a sincere attempt to improve on past mistakes with better science and transparency? Or is it simply a repackaged continuation of a flawed concept, shielded by a fresh face?

Infresh: A Contrast in Transparency

The market for breath fresheners is crowded, but one brand stands apart: Infresh. Unlike both BreathAsure and Zelmin’s, Infresh offers a 100% natural chewable tablet that starts working immediately. Its transparency on ingredients, lack of artificial additives, and proven herbal tradition set it apart.

Where Zelmin’s relies on capsule coatings and vague “clinical” language, Infresh keeps it simple and authentic. Consumers know exactly what they’re getting — and they don’t need to swallow a pill and wait for questionable results.

The Takeaway

The BreathAsure saga remains a cautionary tale of how marketing hype can outpace science. With Zelmin’s, Anthony Raissen’s son Jarred now carries the torch, carefully avoiding the missteps that sank his father’s brand while promoting a near-identical concept.

For consumers, the lesson is clear: history has a way of repeating itself. Slick branding and a new spokesperson don’t erase old problems. Until Zelmin’s proves its claims with solid, independent science, skepticism is warranted.

And for those seeking real, trustworthy solutions to bad breath, products like Infresh — natural, transparent, and effective — show that not every fresh breath fix has to come wrapped in controversy.